Health authorities in Bangladesh have officially confirmed a local outbreak of the Zika virus, with ten laboratory-confirmed cases identified in and around the capital city of Dhaka between September and December 2024, providing conclusive evidence of domestic transmission and raising significant
The rapid integration of artificial intelligence into the pharmacy profession presents a profound and complex dilemma, forcing a critical evaluation of a technology that is simultaneously hailed as a revolutionary tool and flagged as a source of considerable, often poorly understood, risk. While
A new generation of pharmaceutical trade agreements is fundamentally reshaping the landscape of global healthcare, moving beyond abstract economic frameworks to become practical, patient-centric instruments designed to directly enhance the accessibility, affordability, and predictability of
After a period of cautious investor sentiment that chilled the life sciences sector, Aktis Oncology is making a decisive move into the public domain with an initial public offering that could signal a significant turning point for the industry. The company, a specialist in targeted
In the rapidly evolving pharmaceutical landscape, a fundamental strategic shift is underway as the very definition of a valuable brand is being rewritten. While individual product brands like Ozempic and Mounjaro have achieved unprecedented celebrity status and captured the public imagination,
The journey from a promising biological target to a life-saving therapeutic is fraught with challenges, where the quality and reliability of experimental data can mean the difference between a breakthrough and a dead end. For years, the scientific community has relied on established methods to
